Tempus Technology

AI-enabled clinical assistant that provides access to patient insights directly at your fingertips.

• Retrieve patient information

  Quickly access patient information, like report status, results on actionable biomarkers, and MSI/TMB status.

• Filter patients by alterations, genes, or diagnoses

  View relevant cohorts of your patients for additional insights that may support you in patient treatment decisions.

• Identify relevant, up-to-date clinical trials

  Discover the latest clinical trials based on specific patient enrollment criteria so your patients can receive care quickly.

Suite of applications that live inside EHRs.

• Seamless EHR ordering and result delivery

  Place orders and receive results, directly in your EHR.

• Unlock structured genomic data

  Discrete genomic data can power your EHR’s decision-making, advanced analytics, and clinical research.

• Refresh therapies and clinical trials

  Refresh therapies and clinical trials available for your patients based on previous test results – all inside your EHR.

A central platform for researchers and scientists to find, access, and analyze Tempus data.

• Define cohorts of interest

  Apply Inclusion and Exclusion criteria to generate cohorts of interest using our AI assistant.

• Refine and visualize

  Gain insight from quick no-code analyses with Lens Analytical Apps.

• Analyze to uncover critical insights

  Leverage RWD in a flexible computational environment with Lens Workspaces, using R and Jupyter Notebooks.

AI-enabled insights from medical images.

• Automated quantification

  Segments and measures lesions of interest, providing accurate contours and long-axis and short-axis measurements.

• Automated tracking

  Links lesions across time points to create longitudinal tracking reports to calculate lesion response automatically.

• Automated reporting

  Automates therapy response criteria and generates a comprehensive report that can be linked to the patient record in the EMR or Tempus Hub.

Identify and close gaps in care.

• Patient identification

  Identifies patients and contextualizes where they are in the care journey relative to clinical guidelines.

• Notifications in workflow

  Uses tiered and customized notifications driven by physician preferences.

• Tracking across the care continuum

  Tracking for patients who need timely management, lists to search for subsets of patients, and dashboards for real-time insights into a hospital’s patient population.

Our genomic profiling services encompass a broad range of sequencing options, allowing for data-driven patient decisions.

• xT: 648 gene DNA sequencing panel (includes heme malignancies).
• xR: Whole-transcriptome RNA sequencing panel (includes heme malignancies).
• xF/xF+: 105/523 ctDNA sequencing panel.
• xG/xG+: 52/88 gene panel for hereditary cancers.
• xE: Whole exome, 19,000+ gene DNA sequencing panel.
• xM for MRD: Tumor-naive MRD test for recurrence monitoring in colorectal cancer patients.
• xM (NeXT Personal® Dx): Tumor-informed MRD test for recurrence monitoring in NSCLC and breast cancer, as well as response monitoring for IO therapy. (Test by Personalis).

Gain additional insights across multiple cancer types through our algorithmic testing options.

• HRD: Measures homologous recombination deficiency.
• TO: Refines diagnosis for cancers with uncertain origins.
• DPYD: Identifies patients at elevated risk for toxicity to 5 FU and/or capecitabine.
• UGT1A1: Identifies patients at elevated risk for toxicity to irinotecan, sacituzumab govitecan, and/or belinostat.
• PurIST℠: Classifies pancreatic ductal adenocarcinomas into one of two subtypes (basal-like or classical).